FDA Drug Application (200678) for KOMBIGLYZE XR by ASTRAZENECA AB

Back to FDA Applications sponsored by ASTRAZENECA AB

Application Number200678
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage500MG;EQ 5MG BASE
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameKOMBIGLYZE XR
Active IngredientMETFORMIN HYDROCHLORIDE; SAXAGLIPTIN HYDROCHLORIDE



Back to FDA Applications sponsored by ASTRAZENECA AB

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.